Expertise: Sars-CoV-2 vaccines and immunological surveillance

  • Funded by State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
  • Total publications:0 publications

Grant number: 0142005478

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2022
    2022
  • Known Financial Commitments (USD)

    $132,500.38
  • Funder

    State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
  • Principal Investigator

    Dziekan Gerald
  • Research Location

    N/A
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

This mandate is intended to review the scientific literature available worldwide on the subject of vaccines against Sars-CoV-2 and immunological monitoring and to make the findings available to the FOPH. Until October 2022, regular summary reports will be prepared on the latest global findings on vaccines against Sars-CoV-2, e.g. on effectiveness or side effects, as well as on immunological parameters, e.g. on the protective correlate of SARS-CoV-2 antibodies and cellular immune reactions, on the duration of long-term protection after immunization (vaccination and/or infection) or on the level and duration of protection in risk groups. The publications considered will be provided to the FOPH in a suitable format.